Mucosal protective antibodies;Anticorps protecteurs des muqueuses

Annales de l'Institut Pasteur/Actualites

Volumn , Issue SPEC. ISS., 2001, Pages 83-100

  Whaley, K J ^a   Zeitlin, L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PALIVIZUMAB; VIRUS VACCINE; ANTIBODY; CHLAMYDIA ANTIBODY; CHOLERA VACCINE; ENTAMOEBA HISTOLYTICA VACCINE; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY; HERPES SIMPLEX VIRUS 2 ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; INFLUENZA VACCINE; NEISSERIA GONORRHEAE ANTIBODY; PNEUMOCOCCUS VACCINE; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS VACCINE; ROTAVIRUS VACCINE; SALMONELLOSIS VACCINE; TRICHOMONAS VAGINALIS ANTIBODY; UNCLASSIFIED DRUG;

GASTROINTESTINAL TRACT; HUMAN; INFECTION; MUCOSA; NONHUMAN; PASSIVE IMMUNIZATION; PATHOGENESIS; RESPIRATORY TRACT INFECTION; REVIEW; SEXUALLY TRANSMITTED DISEASE; UROGENITAL TRACT INFECTION; ANTIBODY PRODUCTION; CORRELATION ANALYSIS; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SCREENING; GASTROINTESTINAL INFECTION; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; MUCOSAL IMMUNITY; URINARY TRACT INFECTION;

EID: 0034741950     PISSN: 09244204     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Treatment of bacterial vagmosis with an acid cream: A comparison between the effect of lactate-gel and metronidazole
2. Human neutralizing monoclonal antibodies of the IgG subtype protect against mucosal simian-human immunodeficiency virus infection
3. Corn seed production of therapeutic proteins moves forward
4. Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria
5. Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis
6. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection
7. Contraceptive effect of sperm-agglutinating monoclonal antibodies in rabbits
8. Mucus
9. In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant Gram-positive cocci
10. Women's interest in vaginal microbicides
11. Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects
12. Decreased metabolism and viability of Mycoplasma hominis induced by monoclonal antibody-mediated agglutination
13. Urinary sIgA in children with urinary tract infection
14. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora
15. Treatment of bacterial vaginosis in pregnancy with a lactate gel
16. Microbiologic characteristics of Lactobacillus products used for colonization of the vagina
17. Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice
18. Vaginal transmission of HIV-1 in Hu-PBL-SCID mice
19. Function of mucosal immunoglobulins
20. Molecular and cellular basis of immune protection of mucosal surfaces
21. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination
22. Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate
23. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans
24. Cloning and expression of human V-genes derived from phage display libraries as fully assembled human anti-TNF alpha monoclonal antibodies
25. Protection of macaques against vaginal transmission of a pathogenic HIV- 1/SIV chimeric virus by passive infusion of neutralizing antibodies
26. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen
27. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice
28. The industrial production costs of recombinant therapeutic proteins expressed in transgenic corn
29. Antibodies may provide prolonged microbicidal activity due to their long residence time in the vagina
30. Transfer of a functional human immune system to mice with severe combined immunodeficiency
31. The cost of treating community-acquired pneumonia
32. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and mL-chemokine activity by monoclonal antibodies to mLR5
33. Secretory immunoglobulin binding to bacteria in the mouse uterus after mating
34. Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection
35. Oral delivery of antibodies. Future pharmacokinetic trends
36. Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes
37. Salmonella Shigella and Campylobacter: Common bacterial causes of infectious diarrhea
38. Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump
39. Laboratory diagnosis of sexually transmitted diseases in resource-limited settings
40. Infective and anti-infective properties of breastmilk from HIV-1-infected women
41. In vivo IgA coating of anaerobic bacteria in human faeces
42. Bovine immunoglobulin concentrate-clostridium difficile retains C. difficile toxin neutralising activity after passage through the human stomach and small intestine
43. Intranasal antibody prophylaxis for protection against viral disease
44. Preventing infectious disease with passive immunization
45. Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases
46. A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes